Adamis Pharmaceuticals Corporation Stock News

Adamis Pharmaceuticals Corporation (ADMP) with the stream of -0.55% also noticed, India ASE Technology Holding Co., Ltd. (ASX) encountered a rapid change of -3.99% in the last hour of Fridays The post Hair-raising Facts to Know: Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), ASE Technology Holding Co., Ltd. (NYSE:ASX) appeared first on Stocks Equity .

SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid over

SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (NASDAQ) notifying the company that based on the companys filing of its Quarterly Reports on Form 10-Q for the periods ended March 31, 2021, June 30, 2021 and September 30, 2021, the company has regained compliance with NASDAQ Marketplace Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission, and that the matter is now closed.

The stock price of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) fell by over 15% pre-market today. This is why it happened.

Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q3 2021 Result - Earnings Call Transcript

Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET

In todays recent session, 0.89 million shares of the Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) have been traded, and its beta is 1.26. Most recently the companys share price was $0.90, and it changed around $0.0 or 0.22% from the last close, which brings the market valuation of the company to $134.70M. ADMP at last check was Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) Shares Might Go Up 120.80% This Year Read More »

Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reportin

Wall Street brokerages predict that Adamis Pharmaceuticals Co. (NASDAQ:ADMP) will announce earnings of ($0.06) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Adamis Pharmaceuticals earnings, with the lowest EPS estimate coming in at ($0.08) and the highest estimate coming in at ($0.04). Adamis Pharmaceuticals posted earnings []

SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid over

SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announced that it will host an investor conference call on Monday, November 22, 2021 at 2 p.m. Pacific Time to discuss its financial and operating results for the first nine months of 2021, as well as provide a business update. The Company’s press release concerning its financial results will be available after 1 p.m. Pacific Time on November 22, 2021 and on its website at www.adamispharmaceuticals.com , and the company also expects to file its quarterly reports on Form 10-Q for the quarters ended March 31, 2021, June 30, 2021 and September 30, 2021 on that date.

SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdo

DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Global Auto Injector Market Outlook 2030" report has been added to ResearchAndMarkets.com''s offering. The market is estimated to garner a revenue of close to USD 11350 Million by the end of 2030, up from a revenue of about USD 3120 Million in the

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) price closed lower on Monday, November 15, dropping -0.73% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

If you're making a penny stocks watchlist right now, check these three small-caps out The post Top Penny Stocks to Watch Making Big Moves Right Now appeared first on Penny Stocks to Buy, Picks, News a